Symposia: Acute Myeloid Leukemias: Investigational Drug and Cellular Therapies
Program: Oral and Poster Abstracts
Type: Oral
Hematology Disease Topics & Pathways:
Acute Myeloid Malignancies, Research, Clinical trials, AML, Adult, Clinical Research, Diseases, Adverse Events, Myeloid Malignancies, Study Population, Human, Measurable Residual Disease
Type: Oral
Hematology Disease Topics & Pathways:
Acute Myeloid Malignancies, Research, Clinical trials, AML, Adult, Clinical Research, Diseases, Adverse Events, Myeloid Malignancies, Study Population, Human, Measurable Residual Disease
Monday, December 9, 2024: 10:30 AM-12:00 PM
Grand Hall B
(Manchester Grand Hyatt San Diego)
Moderators:
Mathew G. Angelos, MD, PhD,
and
Naval Daver, MD, MD Anderson Cancer Center
Disclosures:
No relevant conflicts of interest to declare.
This session is dedicated to new therapeutics in AML (phase I/II)
10:30 AM
10:45 AM
11:00 AM
11:15 AM
11:30 AM
11:45 AM
See more of: Oral and Poster Abstracts
*signifies non-member of ASH